Henry Grant Morrison, Ii

Title: Henry Grant Morrison, II: Innovator in Pharmaceutical Crystallization

Introduction

Henry Grant Morrison, II is a notable inventor based in Lafayette, Indiana. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel crystalline forms of compounds that have therapeutic applications.

Latest Patents

Morrison holds two patents that focus on crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1). These patents describe various novel crystalline forms designated as Form V through Form XIX. They are characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy. The methods for preparation and pharmaceutical compositions of these forms are particularly useful in treating conditions such as hyperlipidemia, hypercholesterolemia, osteoporosis, and Alzheimer's disease.

Career Highlights

Morrison is associated with Warner-Lambert Company, where he has been instrumental in advancing pharmaceutical research. His work has contributed to the understanding and development of compounds that can significantly impact patient care.

Collaborations

Morrison has collaborated with notable colleagues such as Stephen Robert Byrn and David Andrew Coates. Their combined expertise has fostered innovation in the field of pharmaceutical sciences.

Conclusion

Henry Grant Morrison, II is a distinguished inventor whose work in pharmaceutical crystallization has the potential to improve treatment options for various health conditions. His contributions continue to influence the field and enhance the understanding of drug formulations.